Renal Dosing for Metformin and SGLT2 Inhibitors: When to Adjust in 2025
Dec, 1 2025
Updated 2025 guidelines for metformin and SGLT2 inhibitor dosing in kidney disease. Learn when to adjust doses, when to stop, and how to navigate conflicting FDA labels and clinical evidence.
View More